journal article·2016-03-15Open access

Antibacterial potency of different deposition methods of silver and copper containing diamond-like carbon coated polyethylene

Norbert Harrasser, Sebastian Jüssen, Andreas Obermeir, Ralf Kmeth, Bernd Stritzker, Hans Gollwitzer, Rainer Burgkart

Biomaterials Research· Volume 20· Issue 1

Abstract

Abstract Background Antibacterial coatings of medical devices have been introduced as a promising approach to reduce the risk of infection. In this context, diamond-like carbon coated polyethylene (DLC-PE) can be enriched with bactericidal ions and gain antimicrobial potency. So far, influence of different deposition methods and ions on antimicrobial effects of DLC-PE is unclear. Methods We quantitatively determined the antimicrobial potency of different PE surfaces treated with direct ion implantation (II) or plasma immersion ion implantation (PIII) and doped with silver (Ag-DLC-PE) or copper (Cu-DLC-PE). Bacterial adhesion and planktonic growth of various strains of S. epidermidis were evaluated by quantification of bacterial growth as well as semiquantitatively by determining the grade of biofilm formation by scanning electron microscopy (SEM). Additionally silver release kinetics of PIII-samples were detected. Results (1) A significant ( p < 0.05) antimicrobial effect on PE-surface could be found for Ag- and Cu-DLC-PE compared to untreated PE. (2) The antimicrobial effect of Cu was significantly lower compared to Ag (reduction of bacterial growth by 0.8 (Ag) and 0.3 (Cu) logarithmic (log)-levels). (3) PIII as a deposition method was more effective in providing antibacterial potency to PE-surfaces than II alone (reduction of bacterial growth by 2.2 (surface) and 1.1 (surrounding medium) log-levels of PIII compared to 1.2 (surface) and 0.6 (medium) log-levels of II). (4) Biofilm formation was more decreased on PIII-surfaces compared to II-surfaces. (5) A silver-concentration-dependent release was observed on PIII-samples. Conclusion The results obtained in this study suggest that PIII as a deposition method and Ag-DLC-PE as a surface have high bactericidal effects.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Polymer Nanocomposite Synthesis and Irradiation · Metal and Thin Film Mechanics · Tribology and Wear Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Clinic of Orthopedics and Sports Orthopedics, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str. 22, Munich 81675, Germany.

Experimental Physics IV, Institut für Physik, Augsburg University, Universitätsstr. 1, Augsburg 86135, Germany.

ATOS Clinic, Effnerstr. 38, Munich 81925, Germany.

References (53)

Show source-provided references
1. 10.1016/j.biomaterials.2012.08.01010.1016/j.biomaterials.2012.08.010 ↗
2. Frank RM, Cross MB, Della Valle CJ. Periprosthetic joint infection: modern aspects of prevention, diagnosis, and treatment. J Knee Surg. 2015;28:105–12.
3. 10.1016/j.diagmicrobio.2014.08.01810.1016/j.diagmicrobio.2014.08.018 ↗
4. 10.1016/j.arth.2015.08.04310.1016/j.arth.2015.08.043 ↗
5. 10.3109/17453674.2014.96629010.3109/17453674.2014.966290 ↗
6. 10.5301/hipint.500027710.5301/hipint.5000277 ↗
7. Lu H Liu Y Guo J Wu H Wang J Wu G. Biomaterials with Antibacterial and Osteoinductive Properties to Repair Infected Bone Defects. Int J Mol Sci. 2016;17.10.3390/ijms17030334 ↗
8. 10.1016/j.biomaterials.2015.02.02010.1016/j.biomaterials.2015.02.020 ↗
9. 10.1016/j.biomaterials.2004.01.00810.1016/j.biomaterials.2004.01.008 ↗
10. 10.1016/j.biomaterials.2007.02.03310.1016/j.biomaterials.2007.02.033 ↗
11. 10.1088/1748-6041/8/3/03500910.1088/1748-6041/8/3/035009 ↗
12. 10.1016/j.biomaterials.2004.05.03010.1016/j.biomaterials.2004.05.030 ↗
13. 10.1021/la051330610.1021/la0513306 ↗
14. 10.1007/s10856-005-4422-310.1007/s10856-005-4422-3 ↗
15. 10.1116/1.487143510.1116/1.4871435 ↗
16. 10.1007/s10856-006-9678-810.1007/s10856-006-9678-8 ↗
17. 10.1021/am400318310.1021/am4003183 ↗
18. 10.1016/S0142-9612(00)00306-910.1016/S0142-9612(00)00306-9 ↗
19. 10.1016/0267-6605(93)90078-L10.1016/0267-6605(93)90078-L ↗
20. 10.1007/s10856-014-5252-y10.1007/s10856-014-5252-y ↗
21. 10.1002/jbm.a.3285110.1002/jbm.a.32851 ↗
22. 10.1016/j.surfcoat.2006.09.02210.1016/j.surfcoat.2006.09.022 ↗
23. 10.1016/j.surfcoat.2009.10.04410.1016/j.surfcoat.2009.10.044 ↗
24. 10.1186/s13568-015-0148-x10.1186/s13568-015-0148-x ↗
25. 10.1007/s15010-002-3079-910.1007/s15010-002-3079-9 ↗
26. 10.1056/NEJMra03541510.1056/NEJMra035415 ↗
27. Tilton RC, Rosenberg B. Reversal of the silver inhibition of microorganisms by agar. Appl Environ Microbiol. 1978;35:1116–20.10.1128/aem.35.6.1116-1120.1978 ↗
28. 10.1016/j.arth.2007.10.01710.1016/j.arth.2007.10.017 ↗
29. 10.1111/j.1574-695X.2012.00938.x10.1111/j.1574-695X.2012.00938.x ↗
30. 10.1021/pr034044t10.1021/pr034044t ↗
31. Schwank S, Rajacic Z, Zimmerli W, Blaser J. Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics. Antimicrob Agents Chemother. 1998;42:895–8.10.1128/AAC.42.4.895 ↗
32. Hunter G, Dandy D. The natural history of the patient with an infected total hip replacement. J Bone Joint Surg Br. 1977;59:293–7.10.1302/0301-620X.59B3.893507 ↗
33. Groll J, Fiedler J, Bruellhoff K, Moeller M, Brenner RE. Novel surface coatings modulating eukaryotic cell adhesion and preventing implant infection. Int J Artif Organs. 2009;32:655–62.10.1177/039139880903200915 ↗
34. 10.1016/j.biomaterials.2003.11.03310.1016/j.biomaterials.2003.11.033 ↗
35. 10.1163/15685620332259973410.1163/156856203322599734 ↗
36. 10.1016/j.ijpharm.2011.06.05310.1016/j.ijpharm.2011.06.053 ↗
37. 10.1007/s00284-010-9727-x10.1007/s00284-010-9727-x ↗
38. 10.1016/j.biomaterials.2011.04.04010.1016/j.biomaterials.2011.04.040 ↗
39. 10.5301/ijao.500002210.5301/ijao.5000022 ↗
40. 10.1097/BOT.0b013e3181f9ac8a10.1097/BOT.0b013e3181f9ac8a ↗
41. 10.1088/0957-4484/16/10/05910.1088/0957-4484/16/10/059 ↗
42. 10.1021/la300383810.1021/la3003838 ↗
43. Hardes J, von Eiff C, Streitbuerger A, Balke M, Budny T, Henrichs MP, Hauschild G, Ahrens H. Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. J Surg Oncol. 2010;101:389–95.10.1002/jso.21498 ↗
44. 10.1016/j.solidstatesciences.2009.05.01210.1016/j.solidstatesciences.2009.05.012 ↗
45. 10.1016/S0142-9612(97)00159-210.1016/S0142-9612(97)00159-2 ↗
46. 10.1016/j.triboint.2012.09.00610.1016/j.triboint.2012.09.006 ↗
47. 10.1016/S0257-8972(97)00062-510.1016/S0257-8972(97)00062-5 ↗
48. 10.1016/j.mser.2004.11.00110.1016/j.mser.2004.11.001 ↗
49. 10.1016/S0257-8972(01)01066-010.1016/S0257-8972(01)01066-0 ↗
50. 10.1016/S0002-9343(99)80313-110.1016/S0002-9343(99)80313-1 ↗
51. 10.1021/am400044e10.1021/am400044e ↗
52. 10.1016/j.nano.2006.12.00110.1016/j.nano.2006.12.001 ↗
53. 10.1186/s13568-015-0162-z10.1186/s13568-015-0162-z ↗